Aurora Cannabis (ACB) Cash & Current Investments (2017 - 2025)

Aurora Cannabis (ACB) reported Cash & Current Investments of $77.8 million for Q4 2025, down 46.77% year-over-year from $146.1 million in Q4 2024, and down 24.6% quarter-over-quarter from $103.1 million in Q3 2025.

Aurora Cannabis (ACB) Cash & Current Investments (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has 9 years of Cash & Current Investments data on file, last reported at $77.8 million in Q4 2025.

  • Cash & Current Investments for Q4 2025 came in at $77.8 million, down 46.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $77.8 million (down 46.77% YoY), and the FY2025 annual result was $129.2 million, down 22.56% from the prior year.
  • Cash & Current Investments slipped to $77.8 million in Q4 2025 per ACB's latest filing, from $103.1 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $376.8 million in Q1 2021 and troughed at $77.8 million in Q4 2025.
  • A 5-year average of $219.3 million and a median of $182.9 million in 2023 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2021 and 2023: Cash & Current Investments surged 175.7% in 2021, then plunged 48.98% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $309.0 million in 2021, then retreated by 0.93% to $306.1 million in 2022, then slipped by 23.83% to $233.2 million in 2023, then tumbled by 37.35% to $146.1 million in 2024, then tumbled by 46.77% to $77.8 million in 2025.
  • Business Quant data shows ACB's Cash & Current Investments at $77.8 million in Q4 2025, $103.1 million in Q3 2025, and $134.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 3.74 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 1.94 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 2.15 Bn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 77.77 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 1.32 Bn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 428.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 511.86 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 498.58 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 750.88 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 222.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 77.77 Mn
Sep 30, 2025 103.14 Mn
Jun 30, 2025 134.26 Mn
Mar 31, 2025 129.16 Mn
Dec 31, 2024 146.10 Mn
Sep 30, 2024 127.73 Mn
Jun 30, 2024 149.80 Mn
Mar 31, 2024 103.99 Mn
Dec 31, 2023 233.20 Mn
Sep 30, 2023 176.75 Mn
Jun 30, 2023 175.09 Mn
Mar 31, 2023 189.06 Mn
Dec 31, 2022 306.15 Mn
Sep 30, 2022 329.33 Mn
Jun 30, 2022 343.14 Mn
Mar 31, 2022 308.05 Mn
Dec 31, 2021 309.01 Mn
Sep 30, 2021 322.28 Mn
Jun 30, 2021 345.92 Mn
Mar 31, 2021 376.82 Mn